4.7 (653) · € 28.50 · En Stock
Stryker reported softer sales and installations of its Mako robot in the third quarter, but remains confident in the surgical robot overall.
Stryker's Mako Sales Were 'Super Impressive' in Q4 – OrthoFeed
Medical Device and Wound Care News and Analysis Blog
Stryker on LinkedIn: #wearestryker
Stryker reports third quarter 2023 operating results
Mako Stryker
a120447001_v3.jpg
Stryker: Mako Shoulder And Spine Launches Are On The Way (NYSE:SYK
a120447006_v3.jpg
Stryker Mako - Eminent Medical Center